Access to effective smoking cessation medications in patients with medicare, medicaid and private insurance
Objectives: Compare financial barriers to the most effective smoking cessation medications - varenicline and combination nicotine replacement therapy (CNRT) across major insurance categories and determine whether these financial barriers impact smoking cessation outcomes. Study design: Longitudinal...
Main Authors: | Luisa Masclans, James M. Davis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Public Health in Practice |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666535223000733 |
Similar Items
-
Evaluation of pharmacologic therapies accompanied by behavioural therapy on smoking cessation success: a prospective cohort study in Turkey
by: Kamile Marakoğlu, et al.
Published: (2017-07-01) -
SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking
by: O. D. Ostroumova, et al.
Published: (2018-03-01) -
Does Smoking Affect OSA? What about Smoking Cessation?
by: Athanasia Pataka, et al.
Published: (2022-08-01) -
An integrated approach to pharmacotherapy in smoking cessation: the role of varenicline, bupropion, cytisine, and nicotine replacement therapy
by: Kacper Więcław, et al.
Published: (2023-08-01) -
Smoking quit rates among patients receiving pharmacotherapy who received general practitioner counselling versus intensive counselling: a retrospective cohort study
by: Ilan Yehoshua, et al.
Published: (2022-12-01)